IGI Labs (IG) Cash Flow Statement

Click line-items for a historical chart and %

Net loss
Depreciation	679K
Amortization of license fee	2.15M
Stock-based compensation expense	2.29M
Provision for write down of inventory	1M
Amortization of debt issuance costs	611K
Accounts receivable	-3.17M
Licensing and royalty income receivable	283K
Inventories	-4.36M
Prepaid expenses and other current assets	3.72M
Accounts payable and accrued expenses	2.54M
Deferred income	-475K
Net cash used in operating activities
Capital expenditures	-12.18M
Deposits for capital expenditures
Net cash used in investing activities
Proceeds from note payable, related party
Sale of Series C Convertible preferred stock, net of expenses
Principal payments on capital lease obligation	-70K
Proceeds from exercise of common stock options
Net cash provided by financing activities
Net decrease in cash and cash equivalents	-12.63M
Cash and cash equivalents at beginning of period	87.19M
Cash and cash equivalents at end of period	74.63M
Cash payments for interest	2.7M
Cash payment for taxes
Equipment purchases financed through capital leases
Cashless exercise of warrants
Restricted stock forfeited

Entities mentioned with IG

View All Entities